STABLE COMPOSITION COMPRISING A RETINOID
A stable cosmetic composition with retinoids, using lipophilic antioxidants and light-protecting compounds, addresses instability issues by maintaining retinoid integrity under light and temperature stress, ensuring long-term effectiveness.
Patent Information
- Application Number
- FR2022000441
- Authority / Receiving Office
- FR · FR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-01-19
- Publication Date
- 2024-11-01
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Retinoids in cosmetic compositions are unstable under light and high temperature conditions, leading to discoloration, odor development, and degradation over time.
A composition comprising retinoids, lipophilic antioxidant agents, light-protecting compounds, triglycerides with unsaturated fatty acid residues, and optional polysaccharides or chelating agents, which enhance stability by reducing light transmittance and maintaining retinoid integrity.
The composition maintains retinoids at sufficient residual levels under exposure to light and high temperatures, preventing discoloration, odor, and degradation, ensuring stability and effectiveness over time.
Abstract
Description
Title of the invention: STABLE COMPOSITION COMPRISING A RETINOID Technical field
[0001] The present invention relates to a composition, preferably a cosmetic composition, which is stable and comprises at least one retinoid, context of the art
[0002] Retinoids are known to be useful in the field of, for example, cosmetics because they can function as anti-aging active ingredients that can be used for the treatment of wrinkles and the like. However, they tend to be unstable under certain conditions. For example, retinol is soluble in lipophilic solvents, but the retinol solution can quickly become discolored (yellowing / browning) and the retinol it contains can degrade over time.
[0003] Compositions including one or more retinoids also have stability problems, in that they tend to discolor and develop an unpleasant odor, depending on light or temperature conditions, and the retinoid(s) in the compositions degrade over time upon exposure to light or high temperature. However, sufficient research has not yet been done on the technique for effectively preventing discoloration and unpleasant odor of compositions including one or more retinoids, and degradation due to light or high temperature of the retinoid(s) over time in the compositions. DISCLOSURE OF THE INVENTION
[0004] An objective of the present invention is to provide a composition including at least one retinoid, wherein the composition is stable under conditions of exposure to light and at different temperatures, and can maintain the retinoid in the composition at a sufficient residual level even under conditions of exposure to light and at high temperature.
[0005] The above objective of the present invention can be achieved by a composition, preferably a cosmetic composition, and more preferably a cosmetic composition for the skin, comprising:
[0006] (a) at least one retinoid;
[0007] (b) at least one lipophilic antioxidant agent;
[0008] (c) at least one compound which is capable of imparting to a solution thereof a transmittance of 10% or less, preferably 5% or less, and in a manner more preferably 2% or less, for light having a wavelength of 290 to 420 nm, following a light path length of 10 mm, the concentration of the compound in the solution being 0.9% by weight relative to the total weight of the solution;
[0009] (d) at least one oil chosen from triglycerides, preferably triglycerides having at least one unsaturated fatty acid residue, and more preferably triglycerides having at least one polyunsaturated fatty acid residue; and
[0010] (e) at least one optional polysaccharide, preferably chosen from polysaccharides charides derived from plants, and more preferably chosen from algae extracts.
[0011] The (a) retinoid may be retinol.
[0012] The amount of the (a) retinoid(s) in the composition according to the present invention may be between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, and more preferably between 0.1% and 1% by weight, relative to the total weight of the composition.
[0013] The (b) lipophilic antioxidant agent may be chosen from biodegradable lipophilic antioxidant agents, and preferably tocopherol, pentaerythrityl tetra-di-t-butyl hydroxyhydro-cinnamate, and a mixture thereof.
[0014] The amount of the (b) lipophilic antioxidant agent(s) in the composition according to the present invention may range from 0.01% to 5% by weight, preferably from 0.05% to 3% by weight, and more preferably from 0.1% to 1% by weight, relative to the total weight of the composition.
[0015] The (c) compound may be chosen from polyphenols, preferably quercetin, isoquercetin, rutin, glucosylrutin, and a mixture thereof.
[0016] The amount of the (c) compound in the composition according to the present invention may be between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, and more preferably between 0.1% and 2% by weight, relative to the total weight of the composition.
[0017] The (d) oil may be selected from vegetable oils, preferably from the group consisting of soybean oil, corn oil, cottonseed oil, grapeseed oil, and a mixture thereof.
[0018] The amount of the (d) oil in the composition according to the present invention may range from 0.1% to 20% by weight, preferably from 0.5% to 15% by weight, and more preferably from 1% to 10% by weight, relative to the total weight of the composition.
[0019] The (e) polysaccharide may be chosen from agar, alginate, carrageenan and a mixture thereof.
[0020] The amount of the polysaccharide(s) in the composition according to the present invention may range from 0.001% to 5% by weight, preferably from 0.005% to 2% by weight, and more preferably from 0.01% to 1% by weight, relative to the total weight of the composition.
[0021] If the composition according to the present invention does not comprise (e) polysaccharide, it comprises (b) at least one chelating agent, preferably a biodegradable chelating agent, and more preferably trisodium ethylenediamine disuccinate.
[0022] The amount of the (f) chelating agent(s) in the composition according to the present invention may range from 0.001% to 3% by weight, preferably from 0.005% to 2% by weight, and more preferably from 0.01% to 1% by weight, relative to the total weight of the composition.
[0023] The composition according to the present invention may be in the O / W form, preferably an O / W emulsion or an O / W dispersion, and more preferably an O / W gel emulsion or an O / W gel dispersion.
[0024] The present invention also relates to a cosmetic process for treating a keratinous substance such as the skin, comprising the step of applying the composition according to the present invention to the keratinous substance. Best mode for carrying out the invention
[0025] After diligent research, the inventors have discovered that it is possible to provide a composition including at least one retinoid in which the composition is stable under exposure to light and under different temperature conditions, and can maintain the retinoid therein at a sufficient residual level even under exposure to light and at high temperature.
[0026] The composition according to the present invention can be characterized by a combination of:
[0027] (a) at least one retinoid;
[0028] (b) at least one lipophilic antioxidant agent;
[0029] (c) at least one compound capable of giving its solution a transmittance in less than or equal to 10%, preferably less than or equal to 5%, and more preferably less than or equal to 2%, for light whose wavelength is between 290 and 420 nm, over a light path length of 10 mm, the concentration of the compound in the solution being 0.9% by weight relative to the total weight of the solution;
[0030] (d) at least one oil chosen from triglycerides, preferably triglycerides having at least one unsaturated fatty acid residue, and more preferably triglycerides having at least one polyunsaturated fatty acid residue; and
[0031] (e) at least one optional polysaccharide, preferably chosen from polysaccharides plant-derived charides, and more preferably chosen from algae extracts.
[0032] The composition according to the present invention is stable under exposure to light and under different temperature conditions, and can maintain the retinoid contained therein at a sufficient residual level even under exposure to light and high temperature.
[0033] Ingredient (e) in the composition according to the present invention is optional. Therefore, the composition according to the present invention may or may not comprise ingredient (e).
[0034] If the composition according to the present invention comprises ingredient (e), the composition according to the present invention cannot comprise ingredient (f). The composition according to the present invention which comprises ingredient (e) may be in the form of an O / W gel emulsion or an O / W gel dispersion.
[0035] If the composition according to the present invention does not comprise ingredient (e), the composition according to the present invention comprises ingredient (f). The composition according to the present invention which does not comprise ingredient (e) may be in the form of an O / W emulsion or an O / W dispersion.
[0036] The composition according to the present invention is stable under exposure to light and a variety of temperature conditions. Thus, the term "stable" herein reflects both photostability and thermostability, and means that the conditions, such as appearance, color and odor, of a composition do not change over time under exposure to light (e.g., UV rays) and a variety of constant temperatures such as 4°C, 25°C, 37°C and 45°C.
[0037] Since the composition according to the present invention is stable, it can cause, for example, no or little separation or creaming, no or little discoloration, such as yellowing, and no or little bad odor, for a long period of time. The composition according to the present invention can be stored for a long period of time, since it can cause little or no changes such as creaming, yellowing, and cause bad odor.
[0038] The composition according to the present invention can maintain the (a) retinoid contained therein at a sufficient residual level (such as 80% or more) even under exposure to light (e.g., UV rays) and high temperature (e.g., 45°C). In other words, the degradation of the (a) retinoid in the composition according to the present invention due to light and high temperature can be reduced. Accordingly, the composition according to the present invention can provide cosmetic effects that are stable over time due to the (a) retinoid in the composition.
[0039] Hereinafter, the composition according to the present invention will be explained in more detail.
[0040] [Retinoid]
[0041] The composition according to the present invention comprises (a) at least one retinoid. Two or more (a) retinoids may be used in combination. Thus, a single type of retinoid or a combination of different types of retinoids may be used.
[0042] The (a) retinoid may be retinol (vitamin A), retinal (vitamin A aldehyde), retinoic acid (vitamin A acid), or an ester of retinol and a C2-20 acid such as retinyl propionate, acetate, linoleate, or palmitate (retinyl palmitate).
[0043] For the (a) retinoid, mention may be made of retinol, retinal, retinoic acid, in particular all-trans retinoic acid and 13-cis retinoic acid, retinol derivatives, such as retinol acetate, propionate or palmitate, and the retinoids described in the following patent applications: FR 2 370 377, EP 0 199 636. EP 0 325 540 and EP 0 402 072:
[0044] According to a preferred embodiment of the present invention, the (a) retinoid is retinol or proretinol.
[0045] By "retinol" is meant all isomers of retinol, i.e. all-trans retinol, 13-cis retinol, 11-cis retinol, 9-cis retinol and 3,4-didehydro retinol.
[0046] As a representative of proretinol, retinyl palmitate may be mentioned.
[0047] It is preferable that the (a) retinoid is retinol.
[0048] The amount of the (a) retinoid(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
[0049] On the other hand, the amount of the (a) retinoid(s) in the composition according to the present invention may be 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.
[0050] The amount of the (a) retinoid(s) in the composition according to the present invention may be between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, more preferably between 0.1% and 1% by weight, relative to the total weight of the composition. [0051 ] [Lipophilic antioxidant agent]
[0052] The composition according to the present invention comprises (b) at least one lipophilic antioxidant agent. Only one type of lipophilic antioxidant agent may be used, but two or more different types of lipophilic antioxidant agent may be used in combination.
[0053] According to the present invention, the antioxidant agents are compounds or substances which can trap the various radical forms which may be present in the skin; preferably, they simultaneously trap all the various radical forms present.
[0054] The (b) lipophilic antioxidant agent is different from the (a) retinoid.
[0055] (b) Lipophilic antioxidant agent means that the partition coefficient of the agent an tioxidant between n-butanol and water is >1, more preferably >10 and even more preferably >100.
[0056] As (b) lipophilic antioxidant agents, phenolic antioxidants which have a hindered phenolic structure or a semi-hindered phenolic structure in the molecule may be mentioned. Specific examples of such compounds include
[0057] 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid) whose INCI name is pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, 2,6-di-tert-butyl-4-methylphenol, 2,6-di-tert-butyl-4-ethylphenol, mono- or di- or tri-(a-methylbenzyl)phenol, 2,2'-methylenebis(4-ethyl-6-tert-butylphenol), 2,2'-methylenebis(4-methyl-6-tert-butylphenol), 4,4'-butylidenebis(3-methyl-6-tert-butylphenol), 4,4'-thiobis(3-methyl-6-tert-butylphenol), 2,5-di-tert-butylhydroquinone, 2,5-di-tert-amylhydroquinone, tris[N-(3,5-di-tert-butyl-4-hydroxybenzyl)]isocyanurate, 1,1,3-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, butylidene-l,lbis[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate], octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, tetrakis[methylene-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionato]methane, triethylene glycol bis[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate], 3,9-bis{2-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy]-l,l-dimethylethyl}-2,4,8,10-tetraoxaspiro [5. 5]undecane, l,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 2,2-thiodiethylenebis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], N,N' -hexamethylenebis(3,5-di-tert-butyl-4-hydroxyhydrocinnamide), 1,6-hexanediol bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], l,3,5-tris[(4-tert-butyl-3-hydroxy-2,6-xylyl)methyl]-l,3,5-triazine-2,4,6-trione, 2,4-bis(n-octylthio)-6-(4-hydroxy-3, 5-di-tert-butylanilino)-l,3,5-triazine, acrylate 2-tert-butyl-6-(3'-tert-butyl-5'-methyl-2'-hydroxybenzyl)-4-methylphenyl, 2-[1-(2-hydroxy-3,5-di-tert-pentylphenyl)ethyl]-4,6-di-tert-pentylphenyl acrylate, 4,6-bis[(octylthio)methyl]-o-cresol, 2,4-di-tert-butylphenyl-3,5-di-tert-butyl-4-hydroxybenzoate and 1,6-hexanediolbis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]. ,
[0058] As (b) lipophilic antioxidant agents, mention may also be made of: BHA (butylated hydroxyl anisole) and BHT (butylated hydroxyl toluene), vitamin E (or tocopherols and tocotrienol) and its derivatives, such as the phosphate derivative, for example TPNA® sold by the company Showa Denko, coenzyme Q10 (or ubiquinone), idebenone, certain carotenoids such as lutein, astaxanthin, beta-carotene, phenolic acids and derivatives (for example chlorogenic acid).
[0059] The (b) lipophilic antioxidant agents which may also be mentioned include dithiolanes, for example asparagusic acid, or their derivatives, for example siliceous derivatives of dithiolane, in particular such as those described in patent application FR 2 908 769.
[0060] (b) Lipophilic antioxidant agents which may also be mentioned include:
[0061] glutathione and its derivatives (GSH and / or GSHOEt), such as glutathione alkyl esters (such as those described in patent applications FR 2 704 754 and FR 2 908 769);
[0062] cysteine and its derivatives, such as N-acetylcysteine or L-2-oxothiazolidine-4-carboxylic acid. Reference may also be made to the cysteine derivatives described in patent applications FR 2 877 004 and FR 2 854 160;
[0063] certain defense enzymes against oxidative stress, such as catalase, superoxide dismutase (SOD), lactoperoxidase, glutathione peroxidase and quinone reductases;
[0064] benzylcyclanones; substituted naphthalenones; pidolates (as described in particular in patent application EP 0 511 118); caffeic acid and its derivatives, gamma-oryzanol; melatonin, sulforaphane and extracts containing it (excluding watercress);
[0065] N,N'-bis(benzyl)ethylenediamine-N,N'-diacetic acid diisopropyl ester, as described in particular in patent applications WO 94 / 11338, FR 2 698 095, FR 2 737 205 or EP 0 755 925;
[0066] deferoxamine (or deferai) as described in patent application FR 2 825 920.
[0067] The (b) lipophilic antioxidant agents which can also be used are chalcones, more particularly phloretin or neohesperidin, N,N'-bis(benzyl)ethylenediamine-N,N'-diacetic acid diisopropyl ester or a maritime pine bark extract such as PYCNOGENOL®.
[0068] As examples of (b) lipophilic antioxidant agents, mention may also be made of pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, nordihydro-guaiaretic acid, tocopherol, resveratrol, propyl gallate, butylated hydroxyl toluene, butylated hydroxyl anisole, ascorbyl palmitate, tocopherol, and mixtures thereof.
[0069] It is preferable that the (b) lipophilic antioxidant agent is biodegradable. In this sense, BHT, which is not biodegradable, is not preferable as (b) lipophilic antioxidant agent. Thus, it is preferable not to use BHT as (b) lipophilic antioxidant agent. Furthermore, it is preferable that the composition according to the present invention is free of BHT.
[0070] The term “free” herein means that the composition according to the present invention may contain a limited amount of BHT. However, it is preferable that the amount of BHT is limited such that it is less than 1% by weight, more preferably less than 0.1% by weight, and even more preferably less than 0.01% by weight, relative to the total weight of the composition. It is more preferable that the composition according to the present invention does not comprise BHT.
[0071] More preferably, the lipophilic antioxidant agent (f) is selected from tocopherol, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, and a mixture thereof.
[0072] The amount of the (b) lipophilic antioxidant agent(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
[0073] On the other hand, the amount of the (b) lipophilic antioxidant agent(s) in the composition according to the present invention may be 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.
[0074] The amount of the (b) lipophilic antioxidant agent(s) in the composition according to the present invention may be between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, and more preferably between 0.1% and 1% by weight, relative to the total weight of the composition.
[0075] [Light-shielding compound]
[0076] The composition according to the present invention may comprise (c) at least one compound which is capable of imparting to its solution a transmittance of 10% or less, preferably 5% or less, and more preferably 2% or less, for light of wavelength 290 to 420 nm, along a light path length of 10 mm, wherein the concentration of the (c) compound in the solution is 0.9% by weight relative to the total weight of the solution. Thus, a single type of such a compound or a combination of different types of such compounds may be used.
[0077] The (c) compound can provide low light transmittance. Therefore, the (c) compound can be designated a light-shielding compound.
[0078] It is more preferable that the (c) compound is capable of imparting to a solution a transmittance of zero (0) for light of wavelength 290 to 420 nm along a light path length of 10 mm, wherein the concentration of the (c) compound in the solution is 0.9% by weight relative to the total weight of the solution.
[0079] It is even more preferable that the (c) compound is capable of imparting to a solution a transmittance of zero (0) for light of wavelength from 290 to 420 nm along a light path length of 10 mm, wherein the concentration of the (c) compound in the solution is greater than 0.1% by weight relative to the total weight of the solution.
[0080] The solvent of the solution is not limited as long as the (c) compound is solubilized in the solvent, and the solvent has no absorbance for light having a wavelength of 290 to 420 nm. For example, as the solvent, water and hydrophilic solvents such as ethanol can be used.
[0081] Transmittance may be measured by a spectrophotometer, for example a JASCO Corp. V-750 UV-Visible / NIR spectrophotometer.
[0082] The (c) compound can impart to a solution a transmittance of 10% or less, preferably 5% or less, more preferably 2% or less, and even more preferably zero (0)% for any light of wavelength from 290 to 420 nm along a light path length of 10 mm. In other words, the solution of the (c) compound can reduce or mask any light whose wavelength is between 290 nm and 420 nm.
[0083] The (c) compound can reduce or shield the light with the above specific wavelength which could reach the (a) retinoid in the composition according to the present invention to cause the decomposition of the (a) retinoid. Therefore, the (c) compound can contribute to enhancing the photostability of the retinoid (a), and can reduce the decomposition of the retinoid (a) in the composition according to the present invention.
[0084] The (c) compound may be selected from the group consisting of polyphenols.
[0085] (Polyphenol)
[0086] By the term "polyphenol" is meant a compound containing a plurality of phenolic hydroxyl groups. Phenolic hydroxyl group means a hydroxyl group bonded to an aromatic ring such as a benzene ring and a naphthalene ring. The phenolic hydroxyl group may be optionally etherified or esterified.
[0087] The polyphenol can be chosen from those which have antioxidant activity.
[0088] The polyphenol may be chosen, for example, from flavonoids.
[0089] The preferred flavonoids may correspond to the general formula (I): (I)
[0090] in which
[0091] A", B", C" and D", independently of each other, represent H, -OH, -R' or - OR', where R' represents the residue of a sugar of formula R'OH;
[0092] E” represents H, -OH or -OX', where X' represents:
[0093] F", G" and J" represent, independently of each other, H, -OH or -OCH3; And
[0094] Xi represents -CH2-, -CO- or -CHOH-,
[0095] or the general formula (II):
[0096] in which
[0097] A', C' and D', independently of each other, represent H, -OH, -OCH3, -R' or -OR', where R' represents the residue of a sugar of formula R'OH;
[0098] E' represents H, -OH or -OR', where R' represents the residue of a sugar of formula R'OH; and
[0099] B', F', G' and J', independently of each other, represent H, OH, -OCH3, - OCH2-CH2-OH, or -OR', where R' represents the residue of a sugar of formula R'OH.
[0100] Rutinose, glucose, apiose, rhamnose, robinose, neohesperidose, or a combination thereof, may be mentioned among the R'OH sugars.
[0101] The compounds of formulae (I) and (II) are known. They can be obtained in particular according to the processes described in “The Flavonoids”, Harborne JB, Mabry TJ, Helga Mabry, 1975, pages 1 to 45.
[0102] The flavonoids can be chosen from flavones, flavonols, isoflavones, flavanols, flavanones, anthocyanidins and their mixtures.
[0103] Among the flavonoids that can be used for the present invention, mention may be made of apigenin, apiin, apigetrin, vitexin, chrysin, toringin, luteolin, orientin, galangin, quercetin, isoquercetin, rutin, glucosylrutin, quercitrin, isoquercitrin, kaempferol, astragalin, kaempferitrin, robin, myricetin, daidzein, daidzin, ge- nistein, genistein, glycitein, glycitin, catechin, epicatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, theaflavin, naringenin, narirutin, naringin, hesperetin, hesperidin, glucosylhesperidin, anthocyanidin, an-thocyanin, cyanidin, cyanin, delphinidin, delphinin, pelargonidin, and pe-largonin.
[0104] Some usable polyphenols are present in plants from which they can be extracted in a known manner. It is possible to use extracts of tea leaves (Camellia sinensis or Camellia japonica). In particular, mention will be made of green tea extracts sold under the name SUNPHENON® by the Taiyo Company, which contain flavonoids in particular.
[0105] As polyphenol, it is possible to use a mixture of glucosylrutin and rutin sold under the name ALPHA GLUCOSYL RUTIN by the company QINGDAO TAITONG PHARMACEUTICAL.
[0106] Among the polyphenols which can be used, mention may also be made of polyphenols such as carnosic acid and carmosol which can be extracted, for example, from rosemary, either by extraction followed by distillation (Chang et al., JOSC, Vol. 61, No. 6, June 1984), or by extraction with a polar solvent such as ethanol preceded by extraction with a non-polar solvent such as hexane to remove odorous substances, as described in document EP-A-307,626.
[0107] The polyphenol may also be chosen from (2,5-dihydroxyphenyl)alkylenecarboxylic acids of formula (III) and their derivatives (in particular esters and amides): OH (III) OH
[0108] in which
[0109] Ri" represents -O-Alk, OH or -N(r')(r"), where Alk denotes a linear or branched C1-C20 alkyl, optionally substituted by one or more hydroxyl or alkoxy groups, or a C2-C2o alkenyl,
[0110] r' and r" independently represent H, a C1-C20 alkyl, a C2-C6 hydroxyalkyl or a C3-C6 polyhydroxyalkyl, or r' and r' ' form, together with a nitrogen atom to which they are bonded, a heterocycle,
[0111] r is a number, including zero, such that the chain -(CH2)r-CORi contains at most 21 carbon atoms,
[0112] R2" and R3" independently represent H or a C1-C4 alkyl, R2" being able to besides representing a C1-C4 alkoxy.
[0113] The compounds of formula (III) are known or can be prepared according to known processes, for example analogous to those described in patents FR-2 400 358 and FR-2 400 359.
[0114] The polyphenol can also be chosen from caffeic acid esters or amides.
[0115] Among the caffeic acid esters, mention may in particular be made of the compounds of formula (IV):
[0116] in which
[0117] Z represents a C1-C8 alkyl, for example methyl, or the residue of a phytol.
[0118] Among the caffeic acid amides, mention may in particular be made of the compounds of formula (V):
[0119] in which
[0120] Z' represents a CrC8 alkyl, in particular C6-C8.
[0121] The compounds of formula (IV) or (V) are known or can be prepared according to known methods.
[0122] The (c) compound may be selected from the group consisting of:
[0123] quercetin, isoquercetin, rutin, glucosylrutin, and a mixture thereof.
[0124] The amount of the (c) compound(s) in the composition according to the present invention may be greater than or equal to 0.01% by weight, preferably greater than or equal to 0.05% by weight, and more preferably greater than or equal to 0.1% by weight, relative to the total weight of the composition.
[0125] On the other hand, the amount of the (c) compound(s) in the composition according to the present invention may be 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.
[0126] The amount of the (c) compound(s) in the composition according to the present invention may be between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, and more preferably between 0.1% and 1% by weight, relative to the total weight of the composition.
[0127] [Triglyceride Oil]
[0128] The composition according to the present invention comprises (d) at least one oil selected from triglycerides. Thus, a single type of this oil (d) or a combination of different types of these oils (d) can be used.
[0129] Herein, the term "oil" means a fatty compound or a fatty substance which is in the form of a liquid or a paste (not solid) at room temperature (25 °C) under atmospheric pressure (760 mmHg). As oils, those generally used in cosmetics can be used alone or in combination.
[0130] The (d) oil is selected from triglycerides. Thus, the (d) oil may be referred to as (d) triglyceride oil. Triglyceride is an ester derived from glycerol and three fatty acids, and may be referred to as triacylglycerol.
[0131] It is preferred that the triglyceride for the (d) oil have at least one unsaturated fatty acid residue. In other words, it is preferred that the triglyceride of the (d) oil be an ester derived from glycerol and at least one unsaturated fatty acid. Thus, the triglyceride for the (d) oil may be (i) an ester derived from glycerol and one unsaturated fatty acid and two saturated fatty acids, (ii) an ester derived from glycerol and two unsaturated fatty acids and one saturated fatty acid, or (iii) an ester derived from three unsaturated fatty acids. If two or more unsaturated fatty acids are used, they may be the same or different. If two saturated fatty acids are used, they may be the same or different.
[0132] According to the present invention, the term "unsaturated fatty acid" means a fatty acid comprising at least one carbon-carbon double or triple bond. These are more particularly long-chain fatty acids, i.e. fatty acids which may comprise 8 to 32 carbon atoms, preferably 12 to 26 carbon atoms, and more preferably 14 to 22 carbon atoms.
[0133] Fatty acids may be monounsaturated such as petroselenic acid (C12), palmitoleic acid (C16) and oleic acid (C18), or may be polyunsaturated, i.e. having at least two carbon-carbon double bonds, such as linoleic acid (Cl8) and linolenic acid (Cl8).
[0134] It is more preferable that the triglyceride of the (d) oil has at least one polyunsaturated fatty acid residue. In other words, it is more preferable that the triglyceride for the (d) oil is an ester derived from glycerol and at least one polyunsaturated fatty acid.
[0135] The polyunsaturated fatty acid may be chosen from co-3, co-6 and co-9 fatty acids, characterized by the unsaturation position closest to the terminal methyl group.
[0136] Polyunsaturated fatty acid comprising between 18 and 22 carbon atoms, in particular those chosen from co-3 and co-6 fatty acids, may be more preferable.
[0137] Among the polyunsaturated fatty acids of the co-3 series, mention may be made of a-linolenic acid (18:3, co-3), stearidonic acid (18:4, co-3), 5,8,11,14,17-eicosapentaenoic acid or EPA (20:5, co-3), and 4,7,10,13,16,19-docosahexaenoic acid or DHA (22:6, co-3), docosapentaenoic acid (22,5, co-3) and n-butyl-5,11,14-eicosatrienonic acid.
[0138] Among the polyunsaturated fatty acids of the co-6 series, we can cite linolenic acid with 18 carbon atoms and two unsaturations (18:2, co-6), y-linolenic acid with 18 carbon atoms and three unsaturations (18:3, co-6), dihomogamalinolenic acid with 20 carbon atoms and 3 unsaturations (20:3, co-6), arachidonic acid or 5,8,11,14 eicosatetraenoic acid (20:4, co-6), and docosatetraenoic acid (22:4, co-6).
[0139] As co-9 fatty acid, we can cite Mead's acid (20:3, co-9).
[0140] The polyunsaturated fatty acid may be chosen from α-linolenic acid, γ-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosahexaenoic acid and mixtures thereof.
[0141] The amount of polyunsaturated fatty acid among the fatty acids forming the fatty acid residues in the triglyceride for the (d) oil may be 10% by weight or more, preferably 30% by weight or more, and more preferably 50% by weight or more, relative to the total weight of the fatty acids.
[0142] The weight ratio of amount of polyunsaturated fatty acid(s) / amount of monounsaturated fatty acid(s) among the fatty acids forming the fatty acid residues in the triglyceride for the (d) oil may be greater than 1.0, preferably greater than 1.5, and more preferably greater than 2.0.
[0143] The (d) triglyceride oil can be chosen from vegetable oils.
[0144] For example, the (d) triglyceride oil may be selected from the group consisting of soybean oil, rapeseed oil, cottonseed oil, rice oil, corn oil, grapeseed oil, sesame oil, linseed oil, and a mixture thereof.
[0145] It is preferred that the (d) triglyceride oil is selected from the group consisting of soybean oil, corn oil, cottonseed oil, grapeseed oil and a mixture thereof.
[0146] The amount of the triglyceride oil(s) in the composition according to the present invention may be 0.1% by weight or more, preferably 0.5% by weight or more, and more preferably 1% by weight or more, relative to the total weight of the composition.
[0147] On the other hand, the amount of the triglyceride oil(s) in the composition according to the present invention may be less than or equal to 20% by weight, preferably less than or equal to 15% by weight, and more preferably less than or equal to 10% by weight, relative to the total weight of the composition.
[0148] The amount of the triglyceride oil(s) in the composition according to the present invention may be between 0.1% and 20% by weight, preferably between 0.5% and 15% by weight, more preferably between 1% and 10% by weight, relative to the total weight of the composition.
[0149] The (d) triglyceride oil(s) may form a fatty phase of the composition according to the present invention.
[0150] If the composition according to the present invention is in the form of the O / W type, the (d) triglyceride oil in the composition according to the present invention can form dispersed fatty phases in the O / W type composition.
[0151] [Polysaccharide]
[0152] The composition according to the present invention may comprise (e) at least one polysaccharide. Only one type of polysaccharide may be used, but two or more different types of polysaccharide may be used in combination.
[0153] The (e) polysaccharide may form a capsule which may encapsulate (a) at least one retinoid, preferably together with (d) at least one triglyceride oil, and more preferably together with (b) at least one lipophilic antioxidant agent and (d) at least one triglyceride oil. The encapsulation of the (a) at least one retinoid may further reduce the decomposition of the (a) at least one retinoid, or further reduce the change in appearance or color, or the bad odor of the composition according to the present invention. Thus, the capsule may further improve the stability of the composition according to the present invention.
[0154] The capsule of the (e) at least one polysaccharide including the (a) at least one retinoid may be prepared by surrounding or coating the (a) at least one retinoid with at least one layer or film of the (e) at least one polysaccharide. It is preferable that a mixture comprising the (a) at least one retinoid and the (d) at least one triglyceride oil is surrounded or coated by the (e) at least one polysaccharide. It is more preferably that a mixture comprising (a) at least one retinoid, (b) at least one lipophilic antioxidant agent and (d) at least one triglyceride oil is surrounded or coated by (e) at least one polysaccharide. It is even more preferable that the (a) at least one retinoid is solubilized in the (d) at least one triglyceride oil, and then the (d) at least one triglyceride oil is surrounded or coated by the (e) at least one polysaccharide.The (b) at least one lipophilic antioxidant agent may also be solubilized in the (d) at least one triglyceride oil.
[0155] The coating step may be carried out by any conventional process. For example, it is possible to coextrude (i) a mixture comprising (a) at least one retinoid and (d) at least one triglyceride oil together with (ii) the (e) polysaccharide. In this case, the excluded mixture (i) may form a core, while the polysaccharide (ii) (e) may form a shell. The coextruded core / shell structure may be transformed into a core / shell particle that corresponds to the capsule. The above mixture (i) may also include (b) at least one lipophilic antioxidant agent.
[0156] The shape of the capsule is not limited. For example, the capsule may have the shape of a sphere.
[0157] The size of the capsule is not limited. It is possible that the size or diameter of the capsule is 0.1 to 10 mm, preferably 0.5 to 5 mm, and more preferably 1 to 3 mm.
[0158] The capsule may be dispersed and suspended in the composition of the present invention. The capsule may provide the composition of the present invention with unique aspects.
[0159] It is preferable that the (e) polysaccharide is selected from polysaccharides derived from plants. In other words, it is preferable that the (e) polysaccharide is of plant origin.
[0160] On the other hand, it is also preferable that the (e) polysaccharide is not chosen from cellulose and its derivatives.
[0161] On the other hand, it is also preferable that the (e) polysaccharide is not chosen from cellulose and its derivatives.
[0162] According to the present invention, the term "polysaccharides of plant origin" is understood to mean in particular polysaccharides obtained from the plant kingdom (plants or algae), as opposed to polysaccharides obtained by biotechnological means, as is the case for example for xanthan gum, which is produced in particular by fermentation of a bacterium, Xanthomonas campestris.
[0163] As examples of polysaccharides of plant origin which can be used according to the present invention, mention may in particular be made of:
[0164] a) seaweed extracts, such as alginates, carrageenans and agars, and mixtures thereof. Examples of carrageenans include Satiagum UTC30® and UTC10® from Degussa; as alginate, sodium alginate sold under the name Kelcosol® by ISP may be mentioned;
[0165] b) gums, such as guar gum and its non-ionic derivatives (hydroxypropyl guar), gum arabic, konjac gum or mannan gum, tragacanth gum, ghatti gum, karaya gum or locust bean gum; examples that may be cited include guar gum sold under the name Jaguar HP 105® by the company Rhodia; mannan gum and konjac® (1% gluco-nomannan) sold by the company GfN;
[0166] c) modified or unmodified starches, such as those obtained, for example, from cereals, for example wheat, corn or rice, from legumes, for example blond peas, from tubers, for example potato or cassava starches, and from tapioca; dextrins, such as corn dextrins; we can notably mention Rémy DR I® rice starch sold by the company Rémy; B® corn starch from the Roquette company; potato starch modified with 2-chloroethylaminodipropionic acid neutralized with sodium hydroxide, sold under the name Structure Solanace® by National Starch company; native tapioca starch powder sold under the name Tapioca pure® by National Starch company;
[0167] d) dextrins, such as dextrin extracted from corn under the name Index® from the company National Starch; and
[0168] their mixtures.
[0169] Preferably, the (e) polysaccharide is chosen from algae extracts.
[0170] The seaweed extracts may be chosen from alginates, carrageenans and agars, and mixtures thereof. Preferably, alginates or agars, or mixtures thereof, may be used.
[0171] The amount of the polysaccharide(s) in the composition according to the present invention may be greater than or equal to 0.001% by weight, preferably greater than or equal to 0.005% by weight, and more preferably greater than or equal to 0.01% by weight, relative to the total weight of the composition.
[0172] On the other hand, the amount of the polysaccharide(s) in the composition according to the present invention may be 5% by weight or less, preferably 2% by weight or less, and more preferably 1% by weight or less, relative to the total weight of the composition.
[0173] The amount of the polysaccharide(s) in the composition according to the present invention may be between 0.001% and 5% by weight, preferably between 0.005% and 2% by weight, more preferably between 0.01% and 1% by weight, relative to the total weight of the composition.
[0174] [Chelating agent]
[0175] The composition according to the present invention may comprise (b) at least one chelating agent if it does not comprise (e) polysaccharide. Only one type of chelating agent may be used, but two or more different types of chelating agents may be used in combination.
[0176] As (f) chelating agent, mention may be made of
[0177] (i) aminocarboxylic acids such as the compounds with the following INCI name: acid diethylenetriaminepentaacetic acid (DTPA), ethylenediaminedisuccinic acid (EDDS) and trisodium ethylenediamine disuccinate such as Octaquest E30 from Octel, ethylenediaminetetraacetic acid (EDTA), ethylenediamine-N,N'-diglutaric acid (EDDG), glycinamide-N,N'-disuccinic acid (GADS), 2-hydroxypropylenediamine-N,N'-disuccinic acid (HPDDS), ethylenediamine-N,N'-bis(ortho-hydroxyphenylacetic acid) (EDDHA), N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED), nitrilotriacetic acid (NTA), methylglycine diacetic acid (MGDA), N- 2-hydroxyethyl-N,N-diacetic acid and glyceryl-imino diacetic acid (as described in EP-A-317 542 and EP-A-399 133), iminodiacetic acid-N-2-hydroxypropyl-sulfonic acid and aspartic acid N-car-boxymethyl-N-2-hydroxypropyl-3-sulfonic acid (as described in EP-A-516 102), beta-alanine-N,N'-diacetic acid, aspartic acid-N,N'-diacetic acid and aspartic acid-N-monoacetic acid (as described in EP-A-509 382), iminodisuccinic acid (IDSA) chelating agents (as described in EP-A-509 382), ethanoldiglycine acid, phosphonobutane tricarboxylic acid, such as the compound sold by Bayer under the reference Bayhibit AM, tetrasodium glutamate diacetate (GLDA) such as Dissolvine GL38 or 45S from Akzo Nobel,
[0178] (ii) chelating agents based on mono- or polyphosphonic acid, such as compounds with the following INCI name: diethylenetriaminepenta(methylenephosphonic) acid (DTPMP), ethane-l-hydroxy-l,l acid,2-triphosphonic acid (E1HTP),
[0263] ethane-2-hydroxy-1,1,2-triphosphonic acid (E2HTP), ethane-1-hydroxy-1,1-diphosphonic acid (EHDP), ethane-1,1,2-triphosphonic acid (ETP), ethylenediaminetetramethylenephosphonic acid (EDTMP), and hydroxyethane-1,1-diphosphonic acid (HEDP), and ,
[0179] (iii) polyphosphoric acid-based chelating agents, such as compounds with the following INCI names: sodium tripolyphosphate (STP), tetrasodium diphosphate, hexametaphosphoric acid, sodium metaphosphate, phytic acid, their salts and derivatives,
[0180] and
[0181] their mixtures.
[0182] It is preferable that the (f) chelating agent is biodegradable. In this sense, EDTA, which is not biodegradable, is not preferable as the (f) chelating agent. Thus, it is preferable not to use EDTA as the (f) chelating agent. Furthermore, it is preferable that the composition according to the present invention is free of EDTA.
[0183] The term "free" herein means that the composition according to the present invention may contain a limited amount of EDTA. However, it is preferable that the amount of EDTA is limited such that it is less than 1% by weight, more preferably less than 0.1% by weight, and even more preferably less than 0.01% by weight, relative to the total weight of the composition. It is most preferable that the composition according to the present invention does not comprise EDTA.
[0184] More preferably, the (f) chelating agent is trisodium ethylenediamine di-succinate.
[0185] The amount of the (f) chelating agent(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.005% by weight or more, and more preferably 0.01% by weight or more, relative to the total weight of the composition.
[0186] On the other hand, the amount of the (f) chelating agent(s) in the composition according to the present invention may be less than or equal to 3% by weight, preferably less than or equal to 2% by weight, and more preferably less than or equal to 1% by weight, relative to the total weight of the composition.
[0187] The amount of the (f) chelating agent(s) in the composition according to the present invention may be between 0.001% and 3% by weight, preferably between 0.005% and 2% by weight, more preferably between 0.01% and 1% by weight, relative to the total weight of the composition.
[0188] [Water]
[0189] The composition according to the present invention may comprise water.
[0190] Water may form an aqueous phase of the composition according to the present invention.
[0191] If the composition according to the present invention is in the form of the O / W type, the water in the composition according to the present invention can form a continuous aqueous phase in the O / W type composition.
[0192] The amount of water in the composition according to the present invention may be 50% by weight or more, preferably 55% by weight or more, and more preferably 60% by weight or more, relative to the total weight of the composition.
[0193] On the other hand, the amount of water in the composition according to the present invention may be less than or equal to 90% by weight, preferably less than or equal to 85% by weight, and more preferably less than or equal to 80% by weight, relative to the total weight of the composition.
[0194] The amount of water in the composition according to the present invention may be between 50% and 90% by weight, preferably between 55% and 85% by weight, more preferably between 60% and 80% by weight, relative to the total weight of the composition.
[0195] [Polyol]
[0196] The composition according to the present invention may further comprise at least one polyol. Only one type of polyol may be used, but two or more different types of polyol may be used in combination.
[0197] The term "polyol" herein means an alcohol having two or more hydroxy groups, and does not include a saccharide or a derivative thereof. The derivative of a saccharide includes a sugar alcohol which is obtained by reducing one or more carbonyl groups of a saccharide, as well as a saccharide or a sugar alcohol in which the hydrogen atom or atoms in one or more hydroxy groups thereof has or have been replaced by at least one substituent such as an alkyl group, a hy- droxyalkyl, an alkoxy group, an acyl group or a carbonyl group.
[0198] The polyol may be a C2-C12 polyol, preferably a C2-C9 polyol, comprising at least 2 hydroxy groups, and preferably 2 to 5 hydroxy groups.
[0199] The polyol may be a natural or synthetic polyol. The polyol may have a linear, branched or cyclic molecular structure.
[0200] The polyol may be selected from glycerins and their derivatives, and glycols and their derivatives. The polyol may be selected from the group consisting of glycerin, diglycerin, polyglycerin, ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylyl glycol, 1,3-propanediol, 1,5-pentanediol, polyethylene glycol (5 to 50 ethylene oxide groups) and sugars such as sorbitol.
[0201] The amount of polyol(s) in the composition according to the present invention may be 0.01% by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
[0202] On the other hand, the amount of polyol(s) in the composition according to the present invention may be less than or equal to 20% by weight, preferably less than or equal to 15% by weight, and more preferably less than or equal to 10% by weight, relative to the total weight of the composition.
[0203] Thus, the polyol(s) may be present in the composition according to the present invention in an amount ranging from 0.01% to 20% by weight, and preferably from 0.05% to 15% by weight, such as from 0.1% to 10% by weight, relative to the total weight of the composition.
[0204] [Other ingredients]
[0205] The composition according to the present invention may contain one or more monoalcohols which are in the form of a liquid at room temperature (25°C), such as for example linear or branched monoalcohols comprising from 1 to 6 carbon atoms, such as ethanol, propanol, butanol, isopropanol, isobutanol, pentanol and hexanol.
[0206] The amount of monoalcohol(s) in the composition according to the present invention may be equal to or greater than 0.01% by weight, preferably equal to or greater than 0.1% by weight, and more preferably equal to or greater than 1% by weight, relative to the total weight of the composition.
[0207] On the other hand, the quantity of the monoalcohol(s) in the composition according to the present invention may be less than or equal to 60% by weight, preferably less than or equal to 55% by weight, and more preferably less than or equal to 50% by weight, relative to the total weight of the composition.
[0208] Thus, the amount of monoalcohol(s) in the composition according to the present invention may range from 0.01% to 60% by weight, preferably from 0.1% to 55% by weight, and more preferably from 1% to 50% by weight, relative to the total weight of the composition.
[0209] The composition according to the present invention may also include various adjuvants conventionally used in cosmetic and dermatological compositions, such as anionic, non-ionic, cationic, and amphoteric or zwitterionic polymers, anionic, cationic, amphoteric surfactants, anionic, cationic, amphoteric and non-ionic surfactants, hydrophilic antioxidants, coloring agents, thickeners, sequestering agents, perfumes, dispersing agents, conditioning agents, film-forming agents, preservatives, co-preservatives and mixtures thereof, with the exception of the ingredients as explained above.
[0210] [Preparation]
[0211] The composition according to the present invention can be prepared by mixing the essential ingredient(s) as explained above, and the optional ingredient(s), if necessary, as explained above.
[0212] The method and means for mixing the above essential and optional ingredients are not limited. Any conventional method and means can be used for mixing the above essential and optional ingredients to prepare the composition according to the present invention.
[0213] [Shape]
[0214] The form of the composition according to the present invention is not particularly limited, and may take various forms such as an emulsion (O / W or W / O form), an aqueous gel, an aqueous solution, or the like.
[0215] It is preferable that the composition according to the present invention is in the form of an O / W type. It is more preferred that the composition according to the present invention is in the form of an O / W emulsion or an O / W dispersion which comprises fatty phases dispersed in a continuous aqueous phase. The dispersed fatty phases may be oil droplets in the aqueous phase. It is even more preferable that the composition according to the present invention is in the form of an O / W gel emulsion or an O / W gel dispersion. In this case, the aqueous phase may comprise at least one hydrophilic thickener for gelling the aqueous phase.
[0216] The O / W architecture or structure, which consists of fatty phases dispersed in an aqueous phase, has an external aqueous phase, and therefore the composition according to the present invention with the O / W architecture or structure can provide a pleasant sensation during use thanks to the immediate sensation of freshness that the aqueous phase can provide.
[0217] The composition according to the present invention may be transparent or translucent, preferably transparent.
[0218] Transparency can be measured by measuring turbidity (for example, turbidity can be measured with a 2100Q (marketed by HACH) having a round cell (25 mm in diameter and 60 mm in height) and a tungsten filament lamp capable of emitting visible light (between 400 and 800 nm, preferably 400 to 500 nm). The measurement can be carried out on the undiluted composition. The blank can be determined with distilled water.
[0219] The composition according to the present invention may preferably have a turbidity of less than 200 NTU, preferably less than 150 NTU, more preferably less than 100 NTU, and even more preferably less than 50 NTU.
[0220] [Process and Use]
[0221] It is preferable that the composition according to the present invention is a cosmetic or dermatological composition, preferably a cosmetic composition, and more preferably a cosmetic composition for a keratinous substance such as the skin.
[0222] The composition according to the present invention can be used for a non-therapeutic process, such as a cosmetic process, for treating a keratinous substance such as the skin, hair, mucous membranes, nails, eyelashes, eyebrows and / or the scalp, by being applied to the keratinous substance.
[0223] Thus, the present invention also relates to a cosmetic process for treating a keratinous substance such as the skin, comprising the step of applying the composition according to the present invention to the keratinous substance.
[0224] The composition according to the present invention can be used as, for example, an anti-aging, anti-wrinkle product, or one promoting the renewal of a keratinous substance such as the skin. In particular, the composition according to the present invention can be used as an anti-wrinkle cosmetic product for the skin.
[0225] Another aspect of the present invention relates to a use:
[0226] (b) at least one lipophilic antioxidant agent;
[0227] (c) at least one compound capable of conferring on a solution thereof a trans mittance of 10% or less, preferably 5% or less, and more preferably 2% or less, for light having a wavelength of 290 to 420 nm, following a light path length of 10 mm, the concentration of the compound in the solution being 0.9% by weight relative to the total weight of the solution; and
[0228] (d) at least one oil chosen from triglycerides, preferably tri glycerides having at least one unsaturated fatty acid residue, and more preferably triglycerides having at least one polyunsaturated fatty acid residue,
[0229] for the manufacture of a stable composition comprising (a) at least one retinoid, preferably stable both under exposure to light and under different temperature conditions,
[0230] or
[0231] to reduce the decomposition of the (a) at least one retinoid in a composition comprising the (a) at least one retinoid, both under exposure to light and at high temperature,
[0232] in which
[0233] the composition comprises (e) at least one optional polysaccharide, preferably chosen from plant-derived polysaccharides, and more preferably chosen from algae extracts,
[0234] and
[0235] if the composition does not comprise (e) at least one polysaccharide, the composition comprises (b) at least one chelating agent, preferably a biodegradable chelating agent, and more preferably trisodium ethylenediamine disuccinate.
[0236] Another aspect of the present invention also relates to a process for
[0237] preparing a stable composition comprising (a) at least one retinoid, preferably stable both under exposure to light and under different temperature conditions, or
[0238] reducing the decomposition of (a) at least one retinoid in a composition comprising the (a) at least one retinoid, both under exposure to light and at high temperature,
[0239] comprising one or more addition steps
[0240] (b) at least one lipophilic antioxidant agent;
[0241] (c) at least one compound which is capable of imparting to a solution thereof a transmittance of 10% or less, preferably 5% or less, and more preferably 2% or less, for light of wavelength 290 to 420 nm, following a light path length of 10 mm, the concentration of the compound in the solution being 0.9% by weight relative to the total weight of the solution;
[0242] (d) at least one oil chosen from triglycerides, preferably tri glycerides having at least one unsaturated fatty acid residue, and more preferably triglycerides having at least one polyunsaturated fatty acid residue; and
[0243] (e) at least one optional polysaccharide, preferably chosen from polysaccharides plant-derived charides, and more preferably chosen from algae extracts.
[0244] to the composition,
[0245] in which
[0246] if (e) at least one polysaccharide is not added, the process further comprises a step of adding (b) at least one chelating agent, preferably a biodegradable chelating agent, and more preferably trisodium ethylenediamine di-succinate.
[0247] In the above aspects, it is preferable that the (a) at least one retinoid is encapsulated by the (e) at least one polysaccharide.
[0248] It is more preferable that a mixture comprising (a) at least one retinoid and (d) at least one triglyceride oil is encapsulated by (e) at least one polysaccharide.
[0249] It is even more preferable that a mixture comprising (a) at least one retinoid, (b) at least one lipophilic antioxidant agent, and (d) at least one triglyceride oil is encapsulated by (e) at least one polysaccharide.
[0250] The above explanations regarding ingredients (a) to (f), as well as optional ingredients, for the composition according to the present invention may apply to those for the above uses and processes according to the present invention. The explanations regarding the preparation and forms of the composition according to the present invention may also apply to those of the composition cited in the above uses and processes. EXAMPLES
[0251] The present invention will be described in more detail with the aid of examples which should not, however, be interpreted as limiting the scope of the present invention.
[0252] [Example 1 and Comparative Examples 1-4]
[0253] The following compositions according to Example 1 and Comparative Examples 1-4 in the form of O / W emulsions, shown in Table 1, were prepared by mixing the ingredients shown in Table 1.
[0254] The preparations of the O / W emulsions (example 1 and comparative examples 1-4) were carried out as follows:
[0255] (1) mixing the ingredients of phase B at 75-80°C to form a mixture uniform of phase B;
[0256] (2) cooling the mixture obtained by step (1) above to room temperature;
[0257] (3) add the ingredients of phase A to the uniform mixture of phase B at tem room temperature to form a uniform mixture of phase (A+B);
[0258] (4) mix the ingredients of phase C with a homogenizer at 75-80°C to form a uniform mixture of phase C;
[0259] (5) mixing the ingredients of phase D at room temperature to form a uniform mixing of phase D;
[0260] (6) mixing the uniform mixture of phase (A+B), the uniform mixture of the phase C and the uniform mixture of phase D; and
[0261] (7) homogenize and cool the mixture obtained by step (6) above at the temperature room temperature.
[0262] The numerical values of the component quantities shown in Table 1 are all based on "% by weight" of raw materials.
[0263] [Tables 1] A Ingredients Ex. 1 Ex. 1 comp. Ex. 2 comp. Ex. 3 comp. Ex. 4 comp. Retinol 0.3 0.3 0.3 0.3 0.3 Glycine Soja (Soybean) Oil 2.7 - 2.7 2.7 2.7 B Glycine Soja (Soybean) Oil 2.85 - 2.85 2.85 2.85 Isopropyl Lauroyl Sarcosinate 0.75 6.3 0.75 0.75 0.75 Octyldodecanol 0.15 0.15 0.15 0.15 0.15 Squalane 0.15 0.15 0.15 0.15 0.15 Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate 0.3 0.3 - 0.3 0.3 Tocopherol 0.075 0.075 - 0.075 0.075 C Crosslinked Polymer Acrylates / C10-30 Alkyl Acrylate 0.45 0.45 0.45 0.45 0.45 Sodium Hyaluronate 0.1 0.1 0.1 0.1 0.1 Xanthan Gum (and) Ceratonia Siliqua (Locust Bean) Gum 0.05 0.05 0.05 0.05 0.05 D Caprylyl / Capryl Glucoside (and) Polyglyceryl-10 Isosearate (and) Sodium Dilauramidoglutamide Lysine 0.25 0.25 0.25 0.25 0.25 Fragrance 0.1 0.1 0.1 0.1 0.1 c Hydroxyacetophenone 0.55 0.55 0.55 0.55 0.55 Chlorphenesin 0.3 0.3 0.3 0.3 0.3 Trisodium ethylenediamine disuccinate (37% by weight) 0.15 0.15 0.15 - 0.15 Tris(tetramethylhydroxypiperidinol) citrate 0.46 0.46 0.46 0.46 0.46 Glycerin 10 10 10 10 10 Propanediol 10 10 10 10 10 Caprylyl glycol 0.2 0.2 0.2 0.2 0.2 Dipropylene glycol 2 2 2 2 2 Glucosylrutin (and) rutin 0.9 0.9 0.9 0.9 - Potassium hydroxide 0.16 0.16 0.16 0.16 0.16 Niacinamide 1 1 1 1 1 Caffeine 0.5 0.5 0.5 0.5 0.5 Water qsp 100 qsp 100 qsp 100 qsp 100 qsp 100 Thermo- Stability Residual retinol level (%) Very good Bad Very bad Very bad Good Visual observation Very good Good Good Good Good Photo-Stability Residual retinol level (%) Good Good Good Good Very bad Visual observation Very good Good Good Good Bad e
[0264] [Evaluations]
[0265] (Thermo stability)
[0266] Residual retinol level:
[0267] Each of the compositions according to Example 1 and Comparative Examples 1 to 4 was loaded into a glass bottle and kept under temperature conditions of 45°C for 2 months. The residual retinol level (%) after storage at 45°C for 2 months was measured by HLPC and calculated based on the initial % (24h after production) measured by HPLC. The residual retinol level (%) thus calculated for Each composition was evaluated according to the following criteria.
[0268] Very good: 85 <
[0269] Good: 80 < and < 85
[0270] Bad: 70 < and < 80
[0271] Very bad: < 70
[0272] The results are shown in Table 1.
[0273] Visual observation:
[0274] Each of the compositions according to Example 1 and Comparative Examples 1 to 4 was loaded into four glass bottles, and each of the glass bottles was kept under temperature conditions of 4°C, 25°C, 37°C and 45°C, respectively, for 2 months.
[0275] Each glass bottle was then examined to determine the degree of change (in terms of appearance, color and odor), and evaluated according to the following criteria.
[0276] Very good: pie same condition as at production.
[0277] Good: Little change in appearance, color, or odor was observed.
[0278] Bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad smell) could clearly be observed.
[0279] Very bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad odor) could be observed noticeably.
[0280] The results are shown in Table 1.
[0281] (Photo-Stability)
[0282] Residual retinol level:
[0283] Each of the compositions according to Example 1 and Comparative Examples 1-4 was loaded into a glass bottle and was tested by the Sunlight Test* (24h). The residual retinol level (%) after the sunlight test was measured by HLPC and calculated based on the initial % (24h after production) measured by HPLC. The residual retinol level (%) thus calculated for each composition was evaluated according to the following criteria.
[0284] Very good: 85 <
[0285] Good: 80 < and < 85
[0286] Bad: 70 < and < 80
[0287] Very bad: < 70
[0288] *Sun test
[0289] The glass bottle was exposed to artificial sunlight using SUNTEST CPS+ (Atras) under the following conditions:
[0290] Irradiance: 765 W / m2,
[0291] Temperature: 25°C, and
[0292] Duration of the test: 24 hours.
[0293] The results are shown in Table 1.
[0294] Visual observation:
[0295] Each of the compositions according to Example 1 and Comparative Examples 1-4 was filled into a glass bottle, and the glass bottle was subjected to the above sunlight test.
[0296] Each glass bottle was then examined to determine the degree of change (in terms of appearance, color and odor), and evaluated according to the following criteria.
[0297] Very Good: Almost the same condition as at production.
[0298] Good: Little change in appearance, color, or odor was observed.
[0299] Bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad smell) could clearly be observed.
[0300] Very bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad odor) could be observed noticeably.
[0301] The results are shown in Table 1.
[0302] (Results)
[0303] The composition according to Example 1 which included the ingredients (a) to (d) explained above (the optional ingredient (e) was absent) was stable both under exposure to light and at different temperatures so that the conditions of the composition did not substantially change. Also, the ingredient (a) of the composition according to Example 1 was maintained at a sufficient residual level even under exposure to light and at high temperature.
[0304] The composition according to Comparative Example 1 which did not include ingredient (d) could not maintain ingredient (a) at a sufficient residual level at high temperature.
[0305] The composition according to Comparative Example 2 which did not include ingredient (b) could not maintain ingredient (a) at a sufficient residual level at high temperature.
[0306] The composition according to Comparative Example 3 which did not include ingredient (f) could not maintain ingredient (a) at a sufficient residual level at high temperature.
[0307] The composition according to Comparative Example 4 which did not include ingredient (c) could not maintain ingredient (a) at a sufficient residual level with respect to light.
[0308] [Examples 2-5 and comparative examples 5-7]
[0309] The following compositions according to Examples 2-5 and Comparative Examples 5-7 in the form of encapsulated O / W gel-like dispersions, shown in Table 2, were prepared by mixing the ingredients shown in Table 2.
[0310] The preparations of the encapsulated H / W gel-type dispersions according to Examples 2-5 and Comparative Examples 5-7 were carried out as follows:
[0311] (1) mix the ingredients of phase B at 75-80°C to form a mixture uniform of phase B;
[0312] (2) cooling the mixture obtained by step (1) above to room temperature;
[0313] (3) add the ingredients of phase A to the uniform mixture of phase B at tem room temperature to form a uniform mixture of phase (A+B);
[0314] (4) mix the ingredients of phase C with a homogenizer at 75-80°C to form a uniform mixture of phase C;
[0315] (5) mixing the ingredients of phase D at room temperature to form a uniform mixing of phase D;
[0316] (6) adding the uniform mixture of phase D to the uniform mixture of phase C at room temperature to form a uniform mixture of (C+D);
[0317] (7) mix the ingredients of phase E with a homogenizer at 80-90°C to form a uniform mixture of phase E;
[0318] (8) coextrude the uniform mixture of phase (A+B) and the uniform mixture of the phase E by encapsulating the former with the latter to prepare capsules in which the uniform mixture of phase (A+B) is coated and encapsulated with the uniform mixture of phase E; and
[0319] (9) adding the capsules obtained by step (8) above to the uniform mixture of phase (C+D) at room temperature.
[0320] The numerical values of the component quantities shown in Table 2 are all based on "% by weight" of raw materials.
[0321] [Tables2] A Ingredients Ex. 2 Ex. 3 Ex. 4 Ex. 5 Ex. 5 Comp Ex. 6 Comp Ex. 7 Comp Retinol 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Glycine Soja (Soybean) Oil 2.7 2.7 2.7 2.7 - 2.7 2.7 B Glycine Soja (Soybean) Oil 2.85 2.85 2.85 2.85 - 2.85 2.85 Isopropyl Lauroyl Sarcosinate 0.75 0.75 0.75 0.75 6.3 0.75 0.75 Octyldodecanol 0.15 0.15 0.15 0.15 0.15 0.15 0.15 Squalane 0.15 0.15 0.15 0.15 0.15 0.15 0.15 Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate 0.3 0.3 - 0.3 0.3 - 0.3 Tocopherol 0.075 - 0.5 0.075 0.075 - 0.075 C Crosslinked Polymer Acrylates / C10-30 Alkyl Acrylate 0.45 0.45 0.45 0.45 0.45 0.45 0.45 Sodium Hyaluronate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Xanthan Gum (and) Ceratonia Siliqua (Locust Bean) Gum 0.05 0.05 0.05 0.05 0.05 0.05 0.05 D Caprylyl / Capryl Glucoside (and) Polyglyceryl-10 Isosearate (and) Dilauramidoglutamide Sodium Lysine 0.25 0.25 0.25 0.25 0.25 0.25 0.25 Perfume 0.1 0.1 0.1 0.1 0.1 0.1 0.1 E Agar 0.037 0.037 0.037 0.037 0.037 0.037 0.037 Algin 0.018 0.018 0.018 0.018 0.018 0.018 0.018 Water 3.32 3.32 3.32 3.32 3.32 3.32 3.32 , c Hydroxyacetophenone 0.55 0.55 0.55 0.55 0.55 0.55 0.55 Chlorphenesin 0.3 0.3 0.3 0.3 0.3 0.3 0.3 Trisodium ethylenediamine disuccinate (37% by weight) 0.15 0.15 0.15 - 0.15 0.15 0.15 Tris (tetramethylhydroxypiperidino 1) citrate 0.46 0.46 0.46 0.46 0.46 0.46 0.46 Glycerin 10 10 10 10 10 10 10 Propanediol 10 10 10 10 10 10 10 Propylene glycol - - - - - - - Caprylyl glycol 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Dipropylene glycol 2 2 2 2 2 2 2 Glucosylrutin (and) Rutin 0.9 0.9 0.9 0.9 0.9 0.9 - Potassium hydroxide 0.16 0.16 0.16 0.16 0.16 0.16 0.16 Niacinamide 1 1 1 1 1 1 1 Caffeine 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Water qsp 100 qsp 100 qsp 100 qsp 100 qsp 100 qsp 100 qsp 100 Thermo-Stability Residual retinol level (%) Very good Very good Very good Very good Poor Poor Good Visual observation Very good Very good Very good Good Good Good Good Photo-Stability Residual retinol level (%) Good Very good Very good Good Good Good Very Poor Visual observation Very good Very good Very good Good Good Good Poor ,
[0322] [Evaluations]
[0323] (Thermo stability)
[0324] Residual retinol level:
[0325] Each of the compositions according to Examples 2-5 and Comparative Examples 5-7 has was loaded into a glass bottle and kept under temperature conditions of 45°C for 2 months. The residual retinol content (%) after storage at 45°C for 2 months was measured by HLPC and calculated based on the initial % (24h after production) measured by HPLC. The residual retinol content (%) thus calculated for each composition was evaluated according to the following criteria.
[0326] Very good: 85 <
[0327] Good: 80 < and < 85
[0328] Bad: 70 < and < 80
[0329] Very bad: < 70
[0330] The results are shown in Table 2.
[0331] Visual observation:
[0332] Each of the compositions according to Examples 2-5 and Comparative Examples 5-7 was loaded into four glass bottles, and each of the glass bottles was kept under temperature conditions of 4°C, 25°C, 37°C and 45°C, respectively, for 2 months.
[0333] Each glass bottle was then examined to determine the degree of change (in terms of appearance, color and odor), and evaluated according to the following criteria.
[0334] Very good: Almost the same condition as at production.
[0335] Good: Little change in appearance, color, or odor was observed.
[0336] Bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad smell) could clearly be observed.
[0337] Very bad: A change in appearance (separation or creaming), color (yellowing or browning) or odor (bad odor) could be noticeably observed.
[0338] The results are shown in Table 2.
[0339] (Photo-Stability)
[0340] Residual retinol level:
[0341] Each of the compositions according to Examples 2-5 and Comparative Examples 5-7 was loaded into a glass bottle and was tested by the sunlight test* (24h). The residual retinol level (%) after the sunlight test was measured by HLPC and calculated based on the initial % (24h after production) measured by HPLC. The residual retinol level (%) thus calculated for each composition was evaluated according to the following criteria.
[0342] Very good: 85 <
[0343] Good: 80 < and < 85
[0344] Bad: 70 < and < 80
[0345] Very bad: < 70
[0346] *Sun test
[0347] The glass bottle was exposed to artificial sunlight using SUNTEST CPS+ (Atras) under the following conditions:
[0348] Irradiance: 765 W / m2,
[0349] Temperature: 25°C, and
[0350] Duration of the test: 24 hours.
[0351] The results are shown in Table 2.
[0352] Visual observation:
[0353] Each of the compositions according to Examples 2-5 and Comparative Examples 5-7 was filled into a glass bottle, and the glass bottle was subjected to the above sunlight test.
[0354] Each glass bottle was then examined to determine the degree of change (in terms of appearance, color and odor), and evaluated according to the following criteria.
[0355] Very good: Almost the same condition as at production.
[0356] Good: Little change in appearance, color, or odor was observed.
[0357] Bad: a change in appearance (separation or creaming), color (yellowing or browning) or odor (bad smell) could clearly be observed.
[0358] Very bad: A change in appearance (separation or creaming), color (yellowing or browning) or odor (bad odor) could be noticeably observed.
[0359] The results are shown in Table 2.
[0360] (Results)
[0361] The composition according to Example 2 which included the ingredients (a) to (e) explained above was stable both under exposure to light and at different temperatures so that the conditions of the composition did not substantially change. In addition, the ingredient (a) in the composition according to Example 2 was maintained at a sufficient residual level even under exposure to light and at high temperature.
[0362] The compositions according to Examples 3 and 4, which each included a single ingredient as ingredient (b), were also stable both under exposure to light and at different temperatures, so that the conditions of the compositions did not substantially change. Also, ingredient (a) in the compositions according to Examples 3 and 4 was maintained at a sufficient residual level even under exposure to light and at high temperature.
[0363] The composition according to Example 5 which included ingredient (e) and did not include ingredient (f) was also stable both under exposure to light and at different temperatures such that the conditions of the composition did not substantially change. In addition, ingredient (a) in the composition according to Example 5 was maintained at a sufficient residual rate even under exposure to light and high temperature.
[0364] The composition according to Comparative Example 5 which did not include ingredient (d) could not maintain ingredient (a) at a sufficient residual level at high temperature.
[0365] The composition according to Comparative Example 6 which did not include ingredient (b) could not maintain ingredient (a) at a sufficient residual level at high temperature.
[0366] The composition according to Comparative Example 7 which did not include ingredient (c) could not maintain ingredient (a) at a sufficient residual level with respect to light.
Claims
Claims
1. Composition, preferably cosmetic composition, and more preferably cosmetic composition for the skin, comprising: (a) between 0.01% and 5% by weight, preferably between 0.05% and 3% by weight, and more preferably between 0.1% and 1% by weight, relative to the total weight of the composition, of retinol; (b) at least one lipophilic antioxidant agent chosen from biodegradable lipophilic antioxidant agents, and preferably tocopherol, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, and a mixture thereof;(c) at least one compound which is capable of imparting to a solution thereof a transmittance of 10% or less, preferably 5% or less, and more preferably 2% or less, for light of wavelength 290 to 420 nm, along a light path length of 10 mm, the concentration of the compound in the solution being 0.9% by weight relative to the total weight of the solution, said at least one compound being selected from polyphenols, preferably quercetin, isoquercetin, rutin, glucosylrutin, and a mixture thereof; (d) at least one oil selected from vegetable oils, preferably from the group consisting of soybean oil, corn oil, cottonseed oil, grapeseed oil, and a mixture thereof; and (e) at least one optional polysaccharide, preferably selected from plant-derived polysaccharides, and more preferably from algae extracts.;
2. A composition according to claim 1, wherein the (e) polysaccharide is selected from agar, alginate, carrageenan and a mixture thereof.
3. A composition according to claim 1, wherein the composition does not comprise any (e) polysaccharide, and comprises (f) at least one chelating agent, preferably a biodegradable chelating agent, and more preferably trisodium ethylenediamine disuccinate.
4. The composition according to any one of claims 1 to 3, wherein the composition is in the O / W form, preferably an O / W emulsion or an O / W dispersion, and more preferably an O / W gel emulsion or an O / W gel dispersion.
5. A cosmetic process for treating a keratinous substance such as skin, comprising the step of applying the composition according to any one of claims 1 to 4 to the keratinous substance.
